Oxidant injury in PC12 cells - A possible model of calcium 'dysregulation' in aging: I. Selectivity of protection against oxidative stress

Journal of Neurochemistry

Volumn 69, Issue 3, 1997, Pages 1252-1258

  Joseph, J A ^a   Strain, J G ^a   Jimenez, N D ^a   Fisher, D ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Antioxidants; Calcium; Conotoxin; Nifedipine; Oxidative stress; PC12 cells; Trolox; Phenyl n tert butylnitrone

Indexed keywords

CONOTOXIN; TROLOX C;

AGING; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM METABOLISM; CALCIUM TRANSPORT; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT;

ANIMALIA;

EID: 0030793125     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1997.69031252.x     Document Type: Article

References (40)

1. Adams J. D. Jr., Klaidman L. K., Odunze I. N., Shen H. C., and Miller C. A. (1991) Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol. Chem. 14, 213-225.
2. Ambani L. M., Van Woert M. H., and Murphy S. (1975) Brain peroxidase and catalase in Parkinson disease. Arch. Neurol. 32, 114-118.
3. Behl C., Davis J. B., Lesley R., and Schubert D. (1994) Hydrogen peroxide mediates amyloid β-amyloid protein toxicity. Cell 77, 817-827.
4. 2+-permeable channel-activated by ATP in smooth muscle. Nature 328, 275-278.
5. Benzi G. and Moretti A. (1995) Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging 16, 661-674.
6. Benzi G., Gorini A., Arnaboldi R., Ghigini B., and Villa R. F. (1994) Age-related alterations by chronic intermittent hypoxia on cerebral synaptosomal ATPase activities. J. Neural Transm. Suppl. 44, 159-171.
7. Ceballos-Picot I., Javoy-Agid F., Grimber G., Delacourte A., Defossez A., Lofon M., Hirsch E., Nicole A., Sinet P. M., and Agid Y. (1991) Neuronal localization of copper-zinc superoxide dismutase protein and mRNA within the human hippocampus from control and Alzheimer's disease brains. Free Radic. Res. Commun. 12-13, 571-580.
8. 2+-induced cytotoxicity in PC-12 cells. J. Neurochem. 63, 895-902.
9. Connor J. R., Menzies S. L., St. Martin S. M., and Mufson E. J. (1992) A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains. J. Neurosci. Res. 31, 75-83.
10. Denisova N. A., Strain J. G., and Joseph J. A. (1997) Oxidant injury in PC12 cells - a possible model of calcium "dysregulation" in aging: II. Interactions with membrane lipids. J. Neurochem. 69, 1259-1266.
11. Dexter D. T., Carayon A., Javoy-Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975.
12. 2+ accumulation, storage and release. J. Biol. Chem. 266, 20159-20167.
13. Gibson G. E. and Peterson C. (1987) Calcium and aging in the nervous system. Neurobiol. Aging 8, 329-344.
14. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260, 3440-3450.
15. Halleck M. M., Richburg J. H., and Kauffman F. C. (1992) Reversible and irreversible oxidant injury to PC12 cells by hydrogen peroxide. Free Radic. Biol. Med. 12, 137-144.
16. Hinshaw D. B., Miller M. T., Omann G. M., Beals T. F., and Hyslop P. A. (1993) A cellular model of oxidant-mediated neuronal injury. Brain Res. 615, 13-26.
17. Hirsch E. C. (1993) Does oxidative stress participate in nerve cell death in Parkinson's disease? Eur. Neurol. 33, 52-59.
18. Iredale P. A., Martin K. F., Alexander S. P., Hill S. J., and Kendall D. A. (1992) Inositol 1,4,5-trisphosphate generation and calcium mobilization via activation of an atypical P2 receptor in the neuronal cell line, N1E-115. Br. J. Pharmacol. 107, 1083-1087.
19. +-evoked release of endogenous striatal dopamine: an indicator of altered cholinergic-dopaminergic reciprocal inhibitory control in senescence. Brain Res. 454, 140-148.
20. Joseph J. A., Dalton T. K., Roth G. S., and Hunt W. A. (1988b) Alterations in muscarinic control of striatal dopamine autoreceptors in senescence: a deficit at the ligand-muscarinic receptor interface? Brain Res. 454, 149-155.
21. Joseph J. A., Kowatch M. A., Maki T. and Roth G. S. (1991) Selective cross activation/inhibition of second messenger systems and the reduction of age-related deficits in the muscarinic control of dopamine release from perifused rat striata. Brain Res. 537, 40-48.
22. +-evoked dopamine release from superfused striatal slices: reversals by PBN or Trolox. Free Radic. Biol. Med. 20, 821-830.
23. Jossan S. S., Gillberg P. G., Gottfries C. G., Karlsson I., and Oreland L. (1991) Monoamine oxidase B in brains from patients with Alzheimer's disease: a biochemical and autoradiographical study. Neuroscience 45, 1-12.
24. Kristian T. and Siesjö B. K. (1996) Calcium-related damage in ischemia. Life Sci. 59, 357-367.
25. 2+ pump. J. Biol. Chem. 266, 2520-2525.
26. Landfield P. W. (1994) The role of glucocorticoids in brain aging and Alzheimer's disease: an integrative physiological hypothesis. Exp. Gerontol. 29, 3-11.
27. Landfield P. W. and Eldridge J. C. (1994) The glucocorticoid hypothesis of age-related hippocampal neurodegeneration: role of dysregulated intraneuronal calcium. Ann. NY Acad. Sci. 746, 308-321.
28. Landfield P. W., Thibault O., Mazzanti M. L., Porter N. M., and Kerr D. S. (1992) Mechanisms of neuronal death in brain aging and Alzheimer's disease: role of endocrine-mediated calcium dyshomeostasis. J. Neurobiol. 23, 1247-1260.
29. Lee K. S., Frank S., Vanderklish P., Arai A., and Lynch G. (1991) Inhibition of proteolysis protects hippocampal neurons from ischemia. Proc. Natl. Acad. Sci. USA 88, 7233-7237.
30. 2+-ATPase and calsequestrin genes in rat heart during ontogenic development and aging. Circ. Res. 69, 1380-1388.
31. Lynch D. R. and Dawson T. M. (1994) Secondary mechanisms in neuronal trauma. Curr. Opin. Neurol. 7, 507-509.
32. Martinez-Serrano A., Blanco P., and Satrustegui J. (1992) Calcium binding to cytosol and calcium extrusion mechanisms in intact synaptosomes and their alterations with aging. J. Biol. Chem. 267, 4672-4679.
33. Mattson M. P., Rydel R. E., and Lieberburg I. (1993) Altered calcium signalling and neuronal injury: stroke and Alzheimer's disease as examples. Ann. NY Acad. Sci. 679, 1-21.
34. McCord J. M. (1987) Oxygen-derived radicals: a link between reperfusion injury and inflammation. Fed. Proc. 46, 2402-2406.
35. Pagliusi S. R., Gerrard P., Abdallah M., Talabot D., and Catsicas S. (1994) Age-related changes in expression of AMPA-selective glutamate receptor subunits: is calcium-permeability altered in hippocampal neurons? Neuroscience 61, 429-433.
36. Perry T. L., Godin D. V., and Hansen S. (1982) Parkinson's disease: a disorder due to nigral glutathione deficiency? Neurosci. Lett. 33, 305-310.
37. 2+ transport by free oxygen radicals in vitro. Biochem. Biophys. Res. Commun. 199, 63-69.
38. Saggu H., Cooksey J., Dexter D., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53, 693-697.
39. Subbarao K. V., Richardson J. S., and Ang L. C. (1990) Autopsy samples of Alzheimer's cortex show increased peroxidation in vitro. J. Neurochem. 55, 342-345.
40. 2+ ATPase content is lower in cardicac sarcoplasmic reticulum isolated from old rats. Am. J. Physiol. 264, H1609-H1614.